5-Aminolevulinic Acid Phosphate as an Immune System Enhancer Along with Vaccination Against SARS-CoV-2 Virus...

Area of Science:

• Immunology
• Metabolic Regulation
• Vaccinology

Background:

• 5-aminolevulinic acid phosphate (5-ALA) and sodium ferrous citrate are known metabolic regulators, particularly in T cell metabolism.
• Previous research suggests a role for these compounds in cellular energy and immune function.

Purpose of the Study:

• To assess the safety and tolerability of 5-ALA with sodium ferrous citrate in individuals vaccinated against COVID-19.
• To investigate the potential immune-boosting properties of this supplement when co-administered with COVID-19 vaccines.

Main Methods:

• A randomized, proof-of-concept study involving 200 participants.
• Participants received either the study product with COVID-19 vaccines (Covishield or Covaxin) or vaccination alone (control).
• Safety was monitored via adverse events, tolerability via questionnaires, and immune response via immunoglobulin levels.

Main Results:

• The study product demonstrated excellent safety and tolerability, with no reported safety issues or limitations in well-being.
• Immunoglobulin G levels showed a trend towards immune support, though the results were not statistically significant.
• No adverse events were linked to the administration of 5-ALA with sodium ferrous citrate.

Conclusions:

• 5-aminolevulinic acid phosphate with sodium ferrous citrate is a safe and well-tolerated supplement for individuals receiving COVID-19 vaccines.
• The supplement shows preliminary signals of immune-supportive potential, meriting further research.
• Larger, more comprehensive studies are recommended to confirm these immune-enhancing effects.